| 000 | 01589 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516002152.0 | ||
| 264 | 0 | _c20101228 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1179-2027 | ||
| 024 | 7 |
_a10.2165/11538370-000000000-00000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSignorovitch, James E | |
| 245 | 0 | 0 |
_aComparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. _h[electronic resource] |
| 260 |
_bPharmacoEconomics _c2010 |
||
| 300 |
_a935-45 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aComparative Effectiveness Research _xmethods |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 700 | 1 | _aWu, Eric Q | |
| 700 | 1 | _aYu, Andrew P | |
| 700 | 1 | _aGerrits, Charles M | |
| 700 | 1 | _aKantor, Evan | |
| 700 | 1 | _aBao, Yanjun | |
| 700 | 1 | _aGupta, Shiraz R | |
| 700 | 1 | _aMulani, Parvez M | |
| 773 | 0 |
_tPharmacoEconomics _gvol. 28 _gno. 10 _gp. 935-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/11538370-000000000-00000 _zAvailable from publisher's website |
| 999 |
_c20163391 _d20163391 |
||